Skip to main content

Osteosarcopenia: where bone, muscle, and fat collide

Osteoporosis International volume 28, pages 2781–2790 (2017)Cite this article

Abstract

As the world’s population ages, the prevalence of chronic diseases increases. Sarcopenia and osteoporosis are two conditions that are associated with aging, with similar risk factors that include genetics, endocrine function, and mechanical factors. Additionally, bone and muscle closely interact with each other not only anatomically, but also chemically and metabolically. Fat infiltration, a phenomenon observed in age-related bone and muscle loss, is highly prevalent and more severe in sarcopenic and osteoporotic subjects. Clinically, when individuals suffer a combination of both disorders, negative outcomes such as falls, fractures, loss of function, frailty, and mortality increase, thus generating significant personal and socio-economic costs. Therefore, it is suggested that when bone mineral density loss is synchronic with decreased muscle mass, strength, and function, it should be interpreted as a single diagnosis of osteosarcopenia, which may be preventable and treatable. Simple interventions such as resistance training, adequate protein and calcium dietary intake, associated with maintenance of appropriate levels of vitamin D, have a dual positive effect on bone and muscle, reducing falls, fractures, and, consequently, disability. It is essential that fracture prevention approaches—including postfracture management—involve assessment and treatment of both osteoporosis and sarcopenia. This is of particular importance as in older persons the combination of osteopenia/osteoporosis and sarcopenia has been proposed as a subset of frailer individuals at higher risk of institutionalization, falls, and fractures. This review summarizes osteosarcopenia epidemiology, pathophysiology, diagnosis, outcomes, and management strategies.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3

References

  1. Abimanyi-Ochom J, Watts JJ, Borgström F, Nicholson GC, Shore-Lorenti C, Stuart AL, Zhang Y, Iuliano S, Seeman E, Prince R, March L, Cross M, Winzenberg T, Laslett LL, Duque G, Ebeling PR, Sanders KM (2015) Changes in quality of life associated with fragility fractures: Australian arm of the International Cost and Utility Related to Osteoporotic Fractures Study (AusICUROS). Osteoporos Int 26(6):1781–1790

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Peterson SJ, Braunschweig CA (2016) Prevalence of sarcopenia and associated outcomes in the clinical setting. Nutr Clin Pract 31(1):40–48

    Article  CAS  PubMed  Google Scholar 

  3. Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423

    Article  PubMed  PubMed Central  Google Scholar 

  4. Kanis JA, Adachi JD, Cooper C, Clark P, Cummings SR, Diaz-Curiel M, Harvey N, Hiligsmann M, Papaioannou A, Pierroz D, Silverman SL, Szulc P, the Epidemiology and Quality of Life Working Group of IOF (2013) Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF. Osteoporos Int 24(11):2763–2764

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Curtis E, Litwic A, Cooper C, Dennison E (2015) Determinants of muscle and bone aging. J Cell Physiol 230:2618–2625

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Huo YR, Suriyaarachchi P, Gomez F, Curcio CL, Boersma D, Muir SW, Montero-Odasso M, Gunawardene P, Demontiero O, Duque G (2015) Phenotype of osteosarcopenia in older individuals with a history of falling. J Am Med Dir Assoc 16(4):290–295

    Article  PubMed  Google Scholar 

  7. Crepaldi G, Maggi S (2005) Sarcopenia and osteoporosis: a hazardous duet. J Endocrinol Investig 28:66–68

    Article  CAS  Google Scholar 

  8. Levinger I, Phu S, Duque G (2016) Sarcopenia and osteoporotic fractures. Clin Rev Bone Miner Metab 14(1):38–44

    Article  CAS  Google Scholar 

  9. Binkley N, Buehring B (2009) Beyond FRAX: it’s time to consider “sarco-osteopenia”. J Clin Densitom 12:413–416

    Article  PubMed  Google Scholar 

  10. Frost HM (1997) On our age-related bone loss: insights from a new paradigm. J Bone Miner Res 12:1539–1546

    Article  CAS  PubMed  Google Scholar 

  11. Cheung AM, Papaioannou A, Morin S (2016) Osteoporosis Canada Scientific Advisory Council. Postmenopausal osteoporosis. N Engl J Med 374:2095–2097

    Article  Google Scholar 

  12. Wright NC, Looker A, Saag K, Curtis JR, Dalzell ES, Randall S, Dawson-Hughes B (2014) The re-cent prevalence of osteoporosis and low bone mass based on bone mineral density at the femoral neck or lumbar spine in the United States. J Bone Miner Res 29(11):2520–2526

    Article  PubMed  PubMed Central  Google Scholar 

  13. Office of the Surgeon General (US) (2004) Bone health and osteoporosis: a report of the surgeon general. Office of the Surgeon General (US), Rockville Available from: http://www.ncbi.nlm.nih.gov/books/NBK45513/. Accessed 26 Aug 2016

    Google Scholar 

  14. Amin S, Achenbach SJ, Atkinson EJ, Khosla S, Melton LJ III (2014) Trends in fracture incidence: a population-based study over 20 years. J Bone Miner Res 29:581–589

    Article  PubMed  PubMed Central  Google Scholar 

  15. Cooper C, Campion G, Melton LJ (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285–289

    Article  CAS  PubMed  Google Scholar 

  16. Gullberg B, Johnell O, Kanis JA (1997) World-wide projections for hip fracture. Osteoporos Int 7:407–413

    Article  CAS  PubMed  Google Scholar 

  17. Hughes VA, Frontera WR, Roubenoff R, Evans WJ, Singh MA (2002) Longitudinal changes in body composition in older men and women: role of body weight change and physical activity. Am J Clin Nutr 76:473–481

    CAS  PubMed  Google Scholar 

  18. Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, Corsi AM, Rantanen T, Guralnik JM, Ferrucci L (2003) Age- associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 95:1851–1860

    Article  PubMed  Google Scholar 

  19. Lexell J, Taylor CC, Sjostrom M (1988) What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J Neurol Sci 84(2–3):275–294

    Article  CAS  PubMed  Google Scholar 

  20. von Haehling S, Morley JE, Anker SD (2012) From muscle wasting to sarcopenia and myopenia: up-date. J Cachex Sarcopenia Muscle 3:213–217

    Article  Google Scholar 

  21. Cruz-Jentoft AJ, Landi F, Schneider SM, Zúñiga C, Arai H, Boirie Y, Chen LK, Fielding RA, Martin FC, Michel JP, Sieber C, Stout JR, Studenski SA, Vellas B, Woo J, Zamboni M, Cederholm T (2014) Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43(6):748–759

    Article  PubMed  PubMed Central  Google Scholar 

  22. Di Monaco M, Vallero F, Di Monaco R, Tappero R (2011) Prevalence of sarcopenia and its association with osteoporosis in 313 older women following a hip fracture. Arch Gerontol Geriatr 52:71–74

    Article  PubMed  Google Scholar 

  23. Wang YJ, Wang Y, Zhan JK, Tang ZY, He JY, Tan P, Deng HQ, Huang W, Liu YS (2015) Sarco-osteoporosis: prevalence and association with frailty in Chinese community-dwelling older adults. Int J Endocrinol 2015:482940

    PubMed  PubMed Central  Google Scholar 

  24. Boirie Y (2009) Physiopathological mechanism of sarcopenia. J Nutr Health Aging 13(8):717–723

    Article  CAS  PubMed  Google Scholar 

  25. Karasik D, Kiel DP (2008) Genetics of the musculoskeletal system: a pleiotropic approach. J Bone Miner Res 23:788–802

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Kawao N, Kaji H (2015) Interactions between muscle tissues and bone metabolism. J Cell Biochem 116:687–695

    Article  CAS  PubMed  Google Scholar 

  27. Isaacson J, Brotto M (2014) Physiology of mechanotransduction: how do muscle and bone “talk” to one another? Clin Rev Bone Miner Metab 12:77–85

    Article  PubMed  Google Scholar 

  28. Maugeri D, Russo MS, Franze C, Motta V, Motta M, Destro G, Speciale S, Santangelo A, Panebian-co P, Malaguarnera M (1998) Correlations between C-reactive protein, interleukin-6, tumor necrosis factor-alpha and body mass index during senile osteoporosis. Arch Gerontol Geriatr 27:159–163

    Article  CAS  PubMed  Google Scholar 

  29. Ng A, Duque G (2010) Osteoporosis as a lipotoxic disease. BoneKEy-Osteovision 7:108–123

    Google Scholar 

  30. Demontiero O, Boersma D, Suriyaarachchi P, Duque G (2014) Clinical outcomes of impaired muscle and bone interactions. Clin Rev Bone Miner Metab 12:86–92

    Article  Google Scholar 

  31. Burr DB (1997) Muscle strength, bone mass, and age-related bone loss. J Bone Miner Res 12:1547–1551

    Article  CAS  PubMed  Google Scholar 

  32. Sjoblom S, Suuronen J, Rikkonen T, Honkanen R, Kroger H, Sirola J (2013) Relationship between postmenopausal osteoporosis and the components of clinical sarcopenia. Maturitas 75(2):175–180

    Article  PubMed  Google Scholar 

  33. Mera P, Laue K, Ferron M, Confavreux C, Wei J, Galán-Díez M, Lacampagne A, Mitchell SJ, Matti-son JA, Chen Y, Bacchetta J, Szulc P, Kitsis RN, de Cabo R, Friedman RA, Torsitano C, McGraw TE, Puchowicz M, Kurland I, Karsenty G (2017) Osteocalcin signaling in myofibers is necessary and sufficient for optimum adaptation to exercise. Cell Metab 25(1):218

    Article  CAS  PubMed  Google Scholar 

  34. Sassoli C, Pini A, Chellini F et al (2012) Bone marrow mesenchymal stromal cells stimulate skeletal myoblast proliferation through the paracrine release of VEGF. PLoS One 7(7):e37512

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Tagliaferri C, Wittrant Y, Davicco MJ et al (2015) Muscle and bone, two interconnected tissues. Ageing Res Rev 21:55–57

    Article  CAS  PubMed  Google Scholar 

  36. Kaji H (2014) Interaction between muscle and bone. J Bone Metab 21:29–40

    Article  PubMed  PubMed Central  Google Scholar 

  37. WHO Study Group (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organ Tech Rep Ser 843:1–129

    Google Scholar 

  38. Baim S, Binkley N, Bilezikian JP et al (2008) Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference. J Clin Densitom 11(1):75–91

    Article  PubMed  Google Scholar 

  39. Cosman F, de Beur SJ, LeBoff MS et al (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359–2381

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Nordin C (2011) Screening for osteoporosis: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 155(4):276

    Article  PubMed  Google Scholar 

  41. Papaioannou A, Morin S, Cheung AM et al (2010) Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 182:1864–1873

    Article  PubMed  PubMed Central  Google Scholar 

  42. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR et al (2015) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:755–763

    Article  Google Scholar 

  43. Oliveira A, Vaz C (2015) The role of sarcopenia in the risk of osteoporotic hip fracture. Clin Rheumatol 34(10):1673–1680

    Article  CAS  PubMed  Google Scholar 

  44. Hida T, Harada A, Imagama S, Ishiguro N (2003) Managing sarcopenia and its related-fractures to improve quality of life in geriatric populations. Aging Dis 5(4):226–237

    Google Scholar 

  45. Gonzalez MC, Heymsfield SB (2017) Bioelectrical impedance analysis for diagnosing sarcopenia and cachexia: what are we really estimating? J Cachex Sarcopenia Muscle 8(2):187–189

    Article  Google Scholar 

  46. Rolland Y, Lauwers-Cances V, Cournot M et al (2003) Sarcopenia, calf circumference, and physical function of elderly women: a cross-sectional study. J Am Geriatr Soc 51:1120–1124

    Article  PubMed  Google Scholar 

  47. Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:146–156

    Article  Google Scholar 

  48. Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, Chou MY, Chen LY, Hsu PS, Krairit O, Lee JS, Lee WJ, Lee Y, Liang CK, Limpawattana P, Lin CS, Peng LN, Satake S, Suzuki T, Won CW, Wu CH, Wu SN, Zhang T, Zeng P, Akishita M, Arai H (2014) Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15(2):95–101

    Article  PubMed  Google Scholar 

  49. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M et al (2010) Years live with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2163–2196

    Article  Google Scholar 

  50. Center JR, Nguyen TV, Schneider D (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353:878–882

    Article  CAS  PubMed  Google Scholar 

  51. Braithwaite RS, Col NF, Wong J (2003) Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc 51:354–370

    Article  Google Scholar 

  52. Baumgartner RN, Koehler KM, Gallagher D et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:755–763

    Article  CAS  PubMed  Google Scholar 

  53. Pfisterer MH, Griffiths DJ, Schaefer W, Resnick NM (2006) The effect of age on lower urinary tract function: a study in women. J Am Geriatr Soc 54:405–412

    Article  PubMed  Google Scholar 

  54. Chen HI, Kuo CS (1989) Relationship between respiratory muscle function and age, sex, and other factors. J Appl Physiol 66:943–948

    CAS  PubMed  Google Scholar 

  55. Janssen I, Heymsfield SB, Ross R (2002) Low relative skeletal muscle mass (sarcopenia) in older per-sons is associated with functional impairment and physical disability. J Am Geriatr Soc 50(5):889–896

    Article  PubMed  Google Scholar 

  56. Hairi NN, Cumming RG, Naganathan V, Handelsman DJ, Le Couteur DG, Creasey H et al (2010) Loss of muscle strength, mass (sarcopenia), and quality (specific force) and its relationship with functional limitations and physical disability: the Concord Health and Ageing in Men Project. J Am Geriatr Soc 58:2055–2062

    Article  PubMed  Google Scholar 

  57. Drey M, Sieber CC, Bertsch T, Bauer JM, Schmidmaier R (2015) Osteosarcopenia is more than sarcopenia and osteopenia alone. Aging Clin Exp Res. doi:10.1007/s40520-015-0494-1 Accessed 26 Aug 2016

  58. Huo YR, Suriyaarachchi P, Gomez F, Curcio CL, Boersma D, Gunawardene P, Demontiero O, Duque G (2015) Comprehensive nutritional status in sarco-osteoporotic older fallers. J Nutr Health Aging 19(4):474–480

    Article  CAS  PubMed  Google Scholar 

  59. Yu R, Leung J, Woo J (2014) Incremental predictive value of sarcopenia for incident fracture in an elderly Chinese cohort: results from the Osteoporotic Fractures in Men (MrOs) Study. J Am Med Dir Assoc 15:551–558

    Article  PubMed  Google Scholar 

  60. Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R (2004) The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 52(1):80–85

    Article  PubMed  Google Scholar 

  61. Lippuner K, von Overbeck J, Perrelet R, Bosshard H, Jaeger P (1997) Incidence and direct medical costs of hospitalizations due to osteoporotic fractures in Switzerland. Osteoporos Int 7(5):414–425

    Article  CAS  PubMed  Google Scholar 

  62. Strom O, Borgstrom F, Kanis JA, Compston JE, Cooper C, McCloskey E, Jonsson B (2011) Osteoporosis: burden, health care provision and opportunities in the EU. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Indus-try Associations (EFPIA). Arch Osteoporos 6:59–155

    Article  CAS  PubMed  Google Scholar 

  63. Kanis JA, McCloskey EV, on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) et al (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24(1):23–57

    Article  CAS  PubMed  Google Scholar 

  64. Reginster JY, Beaudart C, Buckinx F, Bruyère O (2016) Osteoporosis and sarcopenia: two diseases or one? Curr Opin Clin Nutr Metab Care 19(1):31–36

    Article  PubMed  Google Scholar 

  65. Rizzoli R, Stevenson JC, Bauer JM et al (2014) The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Maturitas 79:122–132

    Article  CAS  PubMed  Google Scholar 

  66. Daly RM, Duckham RL, Gianoudis J (2014) Evidence for an interaction between exercise and nutrition for improving bone and muscle health. Curr Osteoporos Rep 12:219–226

    Article  PubMed  Google Scholar 

  67. Gianoudis J, Bailey CA, Sanders KM, Nowson CA, Hill K, Ebeling PR, Daly RM (2012) Osteocise: strong bones for life: protocol for a community-based randomised controlled trial of a multi- modal exercise and osteoporosis education program for older adults at risk of falls and fractures. BMC Musculoskelet Disord 13:78

    Article  PubMed  PubMed Central  Google Scholar 

  68. Hunter GR, McCarthy JP, Bamman MM (2004) Effects of resistance training on older adults. Sports Med 34:329–348

    Article  PubMed  Google Scholar 

  69. Choi M, Hector M (2012) Effectiveness of intervention programs in preventing falls: a systematic re-view of recent 10 years and meta-analysis. J Am Med Dir Assoc 13(2):188.13–188.e21

    Article  Google Scholar 

  70. Sherrington C, Whitney JC, Lord SR, Herbert RD, Cumming RG, Close JC (2008) Effective exercise for the prevention of falls: a systematic review and meta-analysis. J Am Geriatr Soc 56(12):2234–2243

    Article  PubMed  Google Scholar 

  71. Holm L, Olesen JL, Matsumoto K et al (2008) Protein-containing nutrient supplementation following strength training enhances the effect on muscle mass, strength, and bone formation in postmenopausal women. J Appl Physiol 105:274–281

    Article  CAS  PubMed  Google Scholar 

  72. Houston DK, Nicklas BJ, Ding J et al (2008) Dietary protein intake is associated with lean mass change in older, community-dwelling adults: the Health, Aging, and Body Composition (Health ABC) Study. Am J Clin Nutr 87:150–155

    CAS  PubMed  Google Scholar 

  73. Deutz NE, Bauer JM, Barazzoni R, Biolo G, Boirie Y, Bosy-Westphal A, Cederholm T, Cruz-Jentoft A, Krznariç Z, Nair KS, Singer P, Teta D, Tipton K, Calder PC (2014) Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clin Nutr 33(6):929–936

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Bauer J, Biolo G, Cederholm T, Cesari M, Cruz-Jentoft AJ, Morley JE, Phillips S, Sieber C, Stehle P, Teta D, Visvanathan R, Volpi E, Boirie Y (2013) Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc 14(8):542–559

    Article  PubMed  Google Scholar 

  75. Bischoff-Ferrari HA, Dietrich T, Orav EJ et al (2004) Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. Am J Clin Nutr 80:752–758

    CAS  PubMed  Google Scholar 

  76. Rizzoli R, Boonen S, Brandi ML et al (2013) Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Curr Med Res Opin 29:305–313

    Article  CAS  PubMed  Google Scholar 

  77. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B (2005) Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 293:2257–2264

    Article  CAS  PubMed  Google Scholar 

  78. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY et al (2004) Effect of vitamin D on falls: a meta-analysis. JAMA 291:1999–2006

    Article  CAS  PubMed  Google Scholar 

  79. Barr R, Macdonald H, Stewart A, McGuigan F, Rogers A, Eastell R et al (2010) Association between vitamin D receptor gene polymorphisms, falls, balance and muscle power: results from two independent studies (APOSS and OPUS). Osteoporos Int 21:457–466

    Article  CAS  PubMed  Google Scholar 

  80. Duque G (2013) Osteoporosis in older persons: current pharmacotherapy and future directions. Expert Opin Pharmacother 14(14):1949–1958

    Article  CAS  PubMed  Google Scholar 

  81. Bradley L, Yaworsky PJ, Walsh FS (2008) Myostatin as a therapeutic target for musculoskeletal disease. Cell Mol Life Sci 65(14):2119–2124

    Article  CAS  PubMed  Google Scholar 

  82. Buehring B, Binkley N (2013) Myostatin—the holy grail for muscle, bone, and fat? Curr Osteoporos Rep 11(4):407–414

    Article  CAS  PubMed  Google Scholar 

  83. Attie KM, Borgstein NG, Yang Y, Condon CH, Wilson DM, Pearsall AE et al (2013) A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers. Muscle Nerve 47(3):416–423

    Article  CAS  PubMed  Google Scholar 

  84. Becker C, Lord SR, Studenski SA, Warden SJ, Fielding RA, Recknor CP et al (2015) Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial. Lancet Diabetes Endocrinol 3(12):948–957

    Article  CAS  PubMed  Google Scholar 

  85. Parise G, Snijders T (2015) Myostatin inhibition for treatment of sarcopenia. Lancet Diabetes Endocrinol 3(12):917–918

    Article  PubMed  Google Scholar 

  86. Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM et al (2010) Adverse events associated with testosterone administration. N Engl J Med 363:109–122

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Papadakis MA, Grady D, Black D, Tierney MJ, Gooding G, Schambelan M et al (1996) Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med 124:708

    Article  CAS  PubMed  Google Scholar 

  88. Thompson J, Butterfield G, Gylfadottir U, Yesavage J, Marcus R, Hintz R et al (1998) Effects of human growth hormone, insulin-like growth factor I, and diet and exercise on body composition of obese postmenopausal women. J Clin Endocrinol Metab 83:1477–1484

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Geriatrics and Gerontology, Federal University of São Paulo, 1500 Sena Madureira Avenue, São Paulo, Brazil

    H. P. Hirschfeld

  2. Australian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western Health, Level 3 WCHRE Building, 176 Furlong Road, St. Albans, VIC, 3021, Australia

    R. Kinsella & G. Duque

  3. Department of Medicine, Melbourne Medical School - Western Health, The University of Melbourne, St. Albans, VIC, 3021, Australia

    G. Duque

Authors
  1. H. P. Hirschfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Kinsella
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Duque
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Duque.

Ethics declarations

Conflicts of interest

None.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hirschfeld, H.P., Kinsella, R. & Duque, G. Osteosarcopenia: where bone, muscle, and fat collide. Osteoporos Int 28, 2781–2790 (2017). https://doi.org/10.1007/s00198-017-4151-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-017-4151-8

Keywords

  • Falls
  • Osteoporosis
  • Osteosarcopenia
  • Sarcopenia
  • Sarco-osteopenia
  • Sarco-osteoporosis